Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. University of Washington School of Medicine, Seattle, WA, United States

Survival: 12.0 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Adriamycin
Country: United States
City/State/Province: Seattle, WA
Hospital: University of Washington School of Medicine
Journal: Link
Date: 6/2003

Patients: This phase I/II study involved a total of 49 women with recurrent platinum resistant ovarian or peritoneal cancer.

Treatment: The treatment consisted of two chemotherapy drugs - gemcitabine and doxorubicin.

Toxicity: Grade 4 toxicities included neutropenia and thrombocytopenia. Grade 3 toxicities inclded nausea, constipation, shortness of breath neurologic, metabolic, and fatigue.

Results: Median survival for the entire group was 12 months.

Support: The study was supported in part by Lilly Oncology. Eli Lilly manufactures or markets gemcitabine (Gemzar).

Correspondence: Barbara A. Goff, MD

E-mail to a Friend More Information